Search Results - "Kesselheim, Aaron S" :: K.UTB vyhledávací portál

Loading…

Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval

by Gyawali, Bishal, Hey, Spencer Phillips, Kesselheim, Aaron S
Published in JAMA internal medicine (01.07.2019)

Get more information

Journal Article

Loading…

What to Know About the Alzheimer Drug Aducanumab (Aduhelm)

by Woloshin, Steven, Kesselheim, Aaron S
Published in JAMA internal medicine (01.08.2022)

Get more information

Journal Article

Loading…

Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration

by Naci, Huseyin, Smalley, Katelyn R, Kesselheim, Aaron S
Published in JAMA : the journal of the American Medical Association (15.08.2017)

Get full text

Journal Article

Loading…

Lifecycle Regulation of Artificial Intelligence– and Machine Learning–Based Software Devices in Medicine

by Hwang, Thomas J, Kesselheim, Aaron S, Vokinger, Kerstin N
Published in JAMA : the journal of the American Medical Association (17.12.2019)

Get full text

Journal Article

Loading…

Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results

by Hwang, Thomas J, Carpenter, Daniel, Lauffenburger, Julie C, Wang, Bo, Franklin, Jessica M, Kesselheim, Aaron S
Published in JAMA internal medicine (01.12.2016)

Get more information

Journal Article

Loading…

Reporting bias in clinical trials: Progress toward transparency and next steps

by Mitra-Majumdar, Mayookha, Kesselheim, Aaron S
Published in PLoS medicine (19.01.2022)

Get full text

Journal Article

Loading…

Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures

by Brown, Beatrice L, Kesselheim, Aaron S, Sarpatwari, Ameet
Published in PLoS medicine (06.03.2023)

Get full text

Journal Article

Loading…

Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

by Vokinger, Kerstin N, Hwang, Thomas J, Grischott, Thomas, Reichert, Sophie, Tibau, Ariadna, Rosemann, Thomas, Kesselheim, Aaron S
Published in The lancet oncology (01.05.2020)

Get full text

Journal Article

Loading…

Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer

by Kesselheim, Aaron S, Myers, Jessica A, Avorn, Jerry
Published in JAMA : the journal of the American Medical Association (08.06.2011)

Get full text

Journal Article

Loading…

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

by Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S, Gyawali, Bishal, Mossialos, Elias
Published in JAMA internal medicine (01.04.2021)

Get more information

Journal Article

Loading…

Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups

by Rome, Benjamin N., Kesselheim, Aaron S.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.08.2023)

Get full text

Journal Article

Loading…

Competition and price among brand-name drugs in the same class: A systematic review of the evidence

by Sarpatwari, Ameet, DiBello, Jonathan, Zakarian, Marie, Najafzadeh, Mehdi, Kesselheim, Aaron S
Published in PLoS medicine (30.07.2019)

Get full text

Journal Article

Loading…

Persistence of resistance: a panel data analysis of the effect of antibiotic usage on the prevalence of resistance

by Rahman, Sakib, Kesselheim, Aaron S., Hollis, Aidan
Published in Journal of antibiotics (01.05.2023)

Get full text

Journal Article

Loading…

New FDA Breakthrough-Drug Category — Implications for Patients

by Darrow, Jonathan J, Avorn, Jerry, Kesselheim, Aaron S
Published in The New England journal of medicine (27.03.2014)

Get full text

Journal Article

Loading…

Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs

by Darrow, Jonathan J, Sarpatwari, Ameet, Avorn, Jerry, Kesselheim, Aaron S
Published in The New England journal of medicine (15.01.2015)

Get full text

Journal Article

Loading…

Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs

by Gyawali, Bishal, Hey, Spencer P., Kesselheim, Aaron S.
Published in EClinicalMedicine (01.04.2020)

Get full text

Journal Article

Loading…

Eroding Judicial Deference to the FDA — Consequences for Public Health

by Daval, C. Joseph Ross, Bendicksen, Liam, Kesselheim, Aaron S.
Published in The New England journal of medicine (16.03.2023)

Get full text

Journal Article

Loading…

Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review

by Wang, Bo, Kesselheim, Aaron S
Published in BMJ (Online) (23.09.2015)

Get full text

Journal Article

Loading…

The Failure of Solanezumab — How the FDA Saved Taxpayers Billions

by Sacks, Chana A, Avorn, Jerry, Kesselheim, Aaron S
Published in The New England journal of medicine (04.05.2017)

Get full text

Journal Article

Loading…

Health policy basics: the Physician Payment Sunshine Act and the Open Payments program

by Kirschner, Neil M, Sulmasy, Lois Snyder, Kesselheim, Aaron S
Published in Annals of internal medicine (07.10.2014)

Get more information

Journal Article

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database